Trials / Completed
CompletedNCT04963660
Primary Immunodeficiencies in Costa Rican Adults
CASE SERIES OF PRIMARY IMMUNODEFICIENCIES IN ADULTS DIAGNOSED IN TWO HOSPITALS OF THE TERTIARY LEVEL OF CARE OF THE COSTA RICAN SOCIAL SECURITY Fund, 2017-2018
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 137 (actual)
- Sponsor
- Caja Costarricense de Seguro Social · Other Government
- Sex
- All
- Age
- 12 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
Primary immunodeficiencies represent a underdiagnosed group of rare diseases which if diagnosed well and in time can be treated in an efficient manner and prevent complications that may affect the quality of patients life in an severe manner. Neither in Costa Rica nor in Central America studies or national registries regarding the prevalence and characterization of primary immunodeficiencies in adult patients exist up to now. This study reflects for the first time the epidemiologic situation of primary immunodeficiencies in a Central American country, characterizing adult patients diagnosed with primary and idiopathic immune disorders treated in two specialized immunodeficiency clinics in Costa Rica.
Conditions
Timeline
- Start date
- 2018-11-11
- Primary completion
- 2019-11-11
- Completion
- 2019-11-11
- First posted
- 2021-07-15
- Last updated
- 2021-07-15
Locations
1 site across 1 country: Costa Rica
Source: ClinicalTrials.gov record NCT04963660. Inclusion in this directory is not an endorsement.